This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Gut (journal) | |
|---|---|
| Title | Gut |
| Discipline | Gastroenterology, Hepatology |
| Abbreviation | Gut |
| Publisher | BMJ Publishing Group |
| Country | United Kingdom |
| Frequency | Monthly |
| History | 1960–present |
| Impact | 39.3 |
| Impact-year | 2023 |
| Issn | 0017-5749 |
Gut (journal) is a monthly peer-reviewed medical journal covering gastroenterology and hepatology with emphasis on clinical practice, translational research, and population studies. Established in 1960, the journal is published by the BMJ Group and serves as a forum for research that influences guidelines, clinical trials, and policy in digestive diseases. Editors, authors, and readers include clinicians and investigators affiliated with institutions such as Mayo Clinic, Massachusetts General Hospital, Johns Hopkins Hospital, Imperial College London, and University of Oxford.
The journal was founded in 1960 during a period of growth in specialty journals following developments at institutions like Royal Free Hospital, Addenbrooke's Hospital, and Hammersmith Hospital. Early editorial leadership included figures who had worked at St Bartholomew's Hospital and University College London Medical School, connecting the title to postwar clinical networks centered on centers such as Guy's Hospital and King's College Hospital. Over subsequent decades the journal published landmark reports that intersected with trials and guideline panels convened by organizations including the National Institute for Health and Care Excellence and the European Association for the Study of the Liver. Editorial stewardship evolved alongside mergers and acquisitions affecting publishers like BMJ Group and collaborations with societies such as the British Society of Gastroenterology and the American Gastroenterological Association.
The journal publishes original research, systematic reviews, meta-analyses, randomized controlled trials, cohort studies, case series, and practice guidelines relevant to clinical services at centers such as Cleveland Clinic, Mount Sinai Hospital (Manhattan), Toronto General Hospital, and Karolinska University Hospital. Topics span diseases and interventions studied at institutions including Mayo Clinic and Memorial Sloan Kettering Cancer Center: inflammatory bowel disease, colorectal cancer screening, pancreatology, hepatocellular carcinoma, endoscopy, esophageal disorders, microbiome studies linked to work at Broad Institute, and translational immunology connected to labs at Harvard Medical School and University of California, San Francisco. The journal regularly features guideline statements and consensus documents developed with societies such as the European Crohn's and Colitis Organisation and the World Gastroenterology Organisation.
The editorial office operates within the BMJ Group structure, with editors recruited from academic centers like University College London, Addenbrooke's Hospital, and University of Edinburgh. The peer review process engages reviewers from networks including American College of Gastroenterology, Asian Pacific Association for the Study of the Liver, and Latin American Association for Gastroenterology, and uses manuscript management systems similar to those employed by journals such as The Lancet and New England Journal of Medicine. Publication frequency is monthly, and the journal issues special supplements aligned with meetings at venues like United European Gastroenterology Week and the annual conferences of the American Association for the Study of Liver Diseases.
Articles are indexed in major bibliographic services including MEDLINE, PubMed Central, Scopus, Web of Science, and databases maintained by organizations such as Clarivate and Elsevier. Citation metrics are tracked alongside titles like The Lancet Gastroenterology & Hepatology, Journal of Hepatology, Clinical Gastroenterology and Hepatology, and Alimentary Pharmacology & Therapeutics for analyses used by panels from agencies including Research England and the National Institutes of Health.
The journal has attained a high impact factor and is frequently cited by guideline-producing bodies such as the National Institute for Health and Care Excellence and trial registries coordinated with ClinicalTrials.gov and the European Clinical Trials Database. Influential publications have shaped practice at institutions including St Mark's Hospital, University of California, San Diego, and Seoul National University Hospital. The title is often compared to premier specialty journals like Journal of Hepatology and Hepatology in bibliometric assessments conducted by entities such as Elsevier and Clarivate Analytics.
The journal has published seminal randomized controlled trials and cohort studies informing colorectal cancer screening policies, hepatitis C antiviral therapy outcomes, and management algorithms for inflammatory bowel disease. Notable contributions include multicenter trials involving collaborators from NIHR-funded units, translational reports tied to the Human Microbiome Project, and population studies using data resources like the UK Biobank. Papers have been cited in guidelines issued by the European Society for Medical Oncology and the American Gastroenterological Association.
Published by the BMJ Group, the journal offers a mixture of subscription and open access options, employing Creative Commons licenses for many articles in line with policies from funders such as the Wellcome Trust, UK Research and Innovation, and the National Institutes of Health. Open access articles appear in repositories like PubMed Central and are discoverable via aggregators used by libraries at institutions including Yale University, Princeton University, and University of Tokyo.
Category:Medical journals Category:Gastroenterology journals